Process View
Any process that activates or increases the frequency, rate or extent of Wnt signaling pathway, planar cell polarity pathway.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of wnt signaling pathway planar cell polarity pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.481 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.405 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.279 | ||
| EGFR | epidermal growth factor receptor | 0.239 | ||
| AFF4 | AF4/FMR2 family, member 4 | 0.237 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.226 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.192 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.188 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.182 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.151 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.125 | ||
| AFF1 | AF4/FMR2 family, member 1 | 0.112 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.077 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.067 | ||
| ABI2 | abl-interactor 2 | 0.045 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.039 | ||
| MSH5 | mutS homolog 5 (E. coli) | 0.033 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.031 | ||
| SPRR2A | small proline-rich protein 2A | 0.027 | ||
| WASF1 | WAS protein family, member 1 | 0.026 | ||
| DOT1L | DOT1-like, histone H3 methyltransferase (S. cerevisiae) | 0.023 | ||
| MUC1 | mucin 1, cell surface associated | 0.022 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.017 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.016 | ||
| RIN1 | Ras and Rab interactor 1 | 0.015 | ||
| CCNT1 | cyclin T1 | 0.015 | ||
| MYO6 | myosin VI | 0.015 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.014 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.012 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.012 | ||
| SHANK3 | SH3 and multiple ankyrin repeat domains 3 | 0.011 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.010 |